Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393361
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-04-28
Brief Title:
ChidamideDecitabine Plus Anti-PD-1 Antibody for Patients With RR cHL Who Are Transplant-ineligible or Refused Transplant
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Organization Data
Organization:
Chinese PLA General Hospital
Class:
OTHER
Study ID:
CHN-PLAGH-BT-085
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chinese PLA General Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Han weidong
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Chinese PLA General Hospital
Old Name:
None
Old Organization:
None